Treatment of glycogenosys type V (McArdle disease) with creatine and ketogenic diet with clinical scores and with 31P-MRS on working leg muscle.
McArdle's disease is caused by genetic defects of the muscle-specific isozyme of glycogen phosphorylase, which block ATP formation from glycogen in skeletal muscle. Creatine supplementation and ketogenic diet have been tested as potential supplements for muscle energy metabolism which may improve muscle symptomatic. Outcome measures were clinical scores describing muscle symptomatic and parameters derived from 31P-MRS examinations on working muscle. In two placebo controlled cross-over studies low dose creatine showed beneficial effects on muscle symptoms and performance whereas high dose creatine distinctly worsened muscle symptomatic in patients. In both studies, however, the absence of an elevation in phosphocreatine indicated the absence of a creatine uptake by the muscle fibre. The effects of creatine on muscle symptomatic may be independent from energy metabolism in muscle. In a case study, ketogenic diet improved muscle symptomatic and performance. However, these effects again did not result in 31P-MRS visible changes in muscle energy metabolism.
Vorgerd
M
M
Department of Neurology, Neuromuscular Centre Ruhrgebiet, Ruhr-University Bochum, Germany. matthias.Vorgerd@rurh-uni-bochum.de
Zange
J
J
D003401:Creatine / Q000627:therapeutic use*; D019587:Dietary Supplements; D006012:Glycogen Storage Disease Type V / Q000178:diet therapy* / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D018482:Muscle, Skeletal / Q000503:physiopathology*; D016896:Treatment Outcome
D003401:Creatine